// App-Quantinova.ai

: Association between exhaled volatile organic compounds and urinary levels of oral corticosteroids within the U-BIOPRED Cohort

Researchers

Presenter

  • Paul Brinkman

Principal Investigators

  • Waqar Ahmed

  • Cristina Gomez

  • Hugo H. Knobel

  • Hans Weda

  • Teunis J. Vink

  • Tamara M. Nijsen

  • Craig E. Wheelock

  • Sven-Erik Dahlen

  • Paolo Montuschi

  • Richard G. Knowles

  • Susanne J. Vijverberg

  • Anke H. Maitland-Van Der Zee

  • Peter J. Sterk

  • Stephen J. Fowler

Medical Centers

  • Department of Respiratory Medicine, Academic Medical Center (AMC), Amsterdam,Netherlands

  • Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom, Manchester, United Kingdom

  • Institute of Environmental Medicine and the Centre for Allergy Research, Stockholm, Sweden

  • Philips Lighting, Eindhoven, Netherlands,

  • Philips Research Eindhoven, Eindhoven, Netherlands

  • Department of Laboratory Medicine, Catholic University of the Sacred Heart, Rome, Italy

  • Knowles Consulting, Stevenage, United Kingdom

  • Manchester Academic Health Science Centre, Manchester University Hospitals NHS Foundation Trust, United Kingdom, Manchester, United Kingdom

Locations

  • Netherlands

  • United Kingdom

  • Sweden

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Volatile organic compounds

Drug/Treatment

  • Prednisolone

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved